4.7 Review

Autoreactive T-Cells in Psoriasis: Are They Spoiled Tregs and Can Therapies Restore Their Functions?

Related references

Note: Only part of the references are listed.
Article Allergy

Pellino-1 promotes intrinsic activation of skin- resident IL-17A-producing T cells in psoriasis

Sung Hee Kim et al.

Summary: Peli1 plays a crucial role in psoriatic inflammation by regulating the activity of skin-resident T17 cells and the NF-kB pathway. Inhibition of Peli1 can alleviate psoriatic lesions by reducing T17 cell activation and NF-kB activation.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)

Review Dermatology

The biological basis of disease recurrence in psoriasis: a historical perspective and current models

Lluis Puig et al.

Summary: One of the challenges in psoriasis therapy is the high recurrence rate of lesions in previously affected areas after treatment discontinuation. This phenomenon is attributed to the persistence of localized immunological 'memory' in resolved skin and the presence of specific T cell subpopulations. Research has shown the importance of the IL-23/Th17 cell pathway in psoriasis immunopathology, suggesting the potential for targeted therapies. IL-17 and IL-23 receptor blockers have demonstrated clinical efficacy in psoriasis treatment.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Article Dermatology

Dimethyl fumarate modulates the Treg-Th17 cell axis in patients with psoriasis

J. Sulaimani et al.

Summary: DMF has been shown to increase the frequency of Treg cells and decrease Th17 cells in patients with psoriasis. It also inhibits T cell activation and proliferation in response to stimulation, while enhancing the resistance of Treg cells to oxidative stress induced by DMF.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Review Dermatology

Role of regulatory T cells in psoriasis pathogenesis and treatment

L. Nussbaum et al.

Summary: Psoriasis is a chronic inflammatory disease with a strong genetic component that can be triggered by environmental factors. Tregs play a fundamental role in immune homeostasis and contribute to the prevention of autoimmune disease by suppressing immune responses, but their functional regulation remains unclear in the context of psoriasis.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Article Immunology

T reg cell-intrinsic requirements for ST2 signaling in health and neuroinflammation

Saskia Hemmers et al.

Summary: The study suggests that ST2 expression on regulatory T cells is not essential for their accumulation and residence in nonlymphoid organs, but cell-intrinsic sensing of IL-33 contributes to cytokine production in certain tissues. Additionally, regulatory T cells play a crucial role in limiting IL-17A-producing gammadelta T cells in the central nervous system.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Dermatology

Time to relapse after tildrakizumab withdrawal in patients with moderate-to-severe psoriasis who were responders at week 28: post hoc analysis through 64 weeks from reSURFACE 1 trial

R. B. Warren et al.

Summary: This study found that tildrakizumab provides durable maintenance of efficacy after treatment interruption, with a median time to loss of PASI 75 response of 5-6 months regardless of dosage. Around 20% of patients did not relapse during the 36-week period, while an increase in body mass index and disease duration were associated with an increased risk of relapse.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Review Cell Biology

Tissue-Resident Memory T Cells in Chronic Inflammation-Local Cells with Systemic Effects?

Anoushka Ashok Kumar Samat et al.

Summary: The article summarizes the role of tissue-resident memory T cells (T-RM) in chronic inflammatory diseases, highlighting the presence of T-RM in both non-lymphoid tissue and circulation, and their potential significance in disease progression and treatment.

CELLS (2021)

Article Immunology

Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29th EADV virtual congress, 29-31 October 2020

Ulrich Mrowietz et al.

Summary: The research demonstrates that dimethyl fumarate (DMF) shows positive efficacy in patients with moderate-to-severe psoriasis, particularly exhibiting strong efficacy in the head and neck region. Patient-reported outcomes such as quality of life and pruritus improved after 24 weeks of treatment with DMF. The safety profile of DMF is similar to fumaric acid esters.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2021)

Article Dermatology

Differential Changes in Inflammatory Mononuclear Phagocyte and T-Cell Profiles within Psoriatic Skin during Treatment with Guselkumab vs. Secukinumab

Heena Mehta et al.

Summary: This study identified the major IL-23+ mononuclear phagocyte and IL-17+T-cell subsets in psoriatic skin lesions, as well as revealed the changes in cellular composition before and during treatment with guselkumab or secukinumab.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2021)

Review Cell Biology

Phenotypic and Functional Diversity in Regulatory T Cells

Louisa E. Sjaastad et al.

Summary: The concept of regulatory T cells (Tregs) as a subset critical for controlling immune responses has been solidified over the past few decades, with FOXP3 and IL2 playing key roles. Recent studies have shown extensive phenotypic and functional diversity within the Treg population.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Immunology

The CCL20 and CCR6 axis in psoriasis

Kazuhisa Furue et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2020)

Article Immunology

Guselkumab in the treatment of moderate-to-severe plaque psoriasis

Cristina Lopez-Sanchez et al.

IMMUNOTHERAPY (2020)

Review Biochemistry & Molecular Biology

Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells

Andreas von Knethen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

Proenkephalin+ regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function

Hiroaki Shime et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Oncology

Selective JAKinibs: Prospects in Inflammatory and Autoimmune Diseases

Anniina T. Virtanen et al.

BIODRUGS (2019)

Review Immunology

Advances in phototherapy for psoriasis and atopic dermatitis

Lajos Kemeny et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)

Article Multidisciplinary Sciences

IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases

Arun K. Kannan et al.

SCIENTIFIC REPORTS (2019)

Article Dermatology

Effect of methotrexate monotherapy on T-cell subsets in the peripheral circulation in psoriasis

M. Priyadarssini et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2019)

Article Multidisciplinary Sciences

Commensal-specific T cell plasticity promotes rapid tissue adaptation to injury

Oliver J. Harrison et al.

SCIENCE (2019)

Review Primary Health Care

The role of gut microbiome in the pathogenesis of psoriasis and the therapeutic effects of probiotics

Dalal Alesa et al.

JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE (2019)

Article Immunology

Foxp3+ T reg cells control psoriasiform inflammation by restraining an IFN-I-driven CD8+ T cell response

Krista Stockenhuber et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Review Immunology

Human FOXP3(+) T regulatory cell heterogeneity

Audrey Mohr et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)

Article Multidisciplinary Sciences

Stability and function of regulatory T cells expressing the transcription factor T-bet

Andrew G. Levine et al.

NATURE (2017)

Review Immunology

The Mechanisms of T Cell Selection in the Thymus

Hiroyuki Takaba et al.

TRENDS IN IMMUNOLOGY (2017)

Review Rheumatology

Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness

Ya-Chu Tsai et al.

THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2017)

Review Allergy

The Inflammatory Response in Psoriasis: a Comprehensive Review

Yaxiong Deng et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)

Review Dermatology

Psoriasis: Behind the scenes

Masutaka Furue et al.

JOURNAL OF DERMATOLOGY (2016)

Article Immunology

Cutting Edge: Regulatory T Cells Facilitate Cutaneous Wound Healing

Audrey Nosbaum et al.

JOURNAL OF IMMUNOLOGY (2016)

Article Immunology

Characterization of Th17 and FoxP3+ Treg Cells in Paediatric Psoriasis Patients

L. Zhang et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2016)

Review Immunology

Interleukin-33 in health and disease

Foo Yew Liew et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Dermatology

An Update on Topical Therapies for Mild-Moderate Psoriasis

Peter C. M. van de Kerkhof

DERMATOLOGIC CLINICS (2015)

Article Immunology

Melanocyte antigen triggers autoimmunity in human psoriasis

Akiko Arakawa et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2015)

Article Medicine, Research & Experimental

Memory regulatory T cells reside in human skin

Robert Sanchez Rodriguez et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Biochemistry & Molecular Biology

Pathogenic conversion of Foxp3(+) T cells into T(H)17 cells in autoimmune arthritis

Noriko Komatsu et al.

NATURE MEDICINE (2014)

Article Multidisciplinary Sciences

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

Roberto Lande et al.

NATURE COMMUNICATIONS (2014)

Article Orthopedics

RANKL-RANK interaction in immune regulatory systems

Taishin Akiyama et al.

WORLD JOURNAL OF ORTHOPEDICS (2012)

Article Medicine, Research & Experimental

GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice

Elizabeth A. Wohlfert et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Dermatology

CD4+CD25+T-regulatory cells in psoriasis. Correlation between their numbers and biologics-induced clinical improvement

Antonio Giovanni Richetta et al.

EUROPEAN JOURNAL OF DERMATOLOGY (2011)

Letter Dermatology

Infliximab therapy induces increased polyclonality of CD4+CD25+regulatory T cells in psoriasis

L. Diluvio et al.

BRITISH JOURNAL OF DERMATOLOGY (2010)

Article Multidisciplinary Sciences

Protein Kinase C-θ Mediates Negative Feedback on Regulatory T Cell Function

Alexandra Zanin-Zhorov et al.

SCIENCE (2010)

Review Pharmacology & Pharmacy

VITAMIN D ANALOGUE-BASED THERAPIES FOR PSORIASIS

J. L. O'Neill et al.

DRUGS OF TODAY (2010)

Review Immunology

IL-17 and Th17 Cells

Thomas Korn et al.

ANNUAL REVIEW OF IMMUNOLOGY (2009)

Article Immunology

Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis

Leslie van der Fits et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Immunology

IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells

Wendy A. Goodman et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Pharmacology & Pharmacy

The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation

Jean-Pierre Evenou et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)

Article Medicine, Research & Experimental

The PKC inhibitor AEB071 may be a therapeutic option for psoriasis

Hans Skvara et al.

JOURNAL OF CLINICAL INVESTIGATION (2008)

Review Immunology

T-cell fate and function: PKC-theta and beyond

Benjamin J. Marsland et al.

TRENDS IN IMMUNOLOGY (2008)

Review Dermatology

Triggering psoriasis: the role of infections and medications

Lionel Fry et al.

CLINICS IN DERMATOLOGY (2007)

Article Medicine, General & Internal

Psoriasis 1 - Pathogenesis and clinical features of psoriasis

Christopher E. M. Griffiths et al.

LANCET (2007)

Article Multidisciplinary Sciences

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

Daniel Mucida et al.

SCIENCE (2007)

Article Biochemistry & Molecular Biology

Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells

Karin Loser et al.

NATURE MEDICINE (2006)

Review Allergy

Update on glucocorticoid action and resistance

DYM Leung et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)